Mechanism of induction of cell-mediated immunity to virus infections: in vitro inhibition of intracellular multiplication of mouse adenovirus by immune spleen cells.

Por Hamada, C, Uetake, H
Publicado em 1975

Statistical characterization of negative control data in the Ames Salmonella/microsome test.

Por Hamada, C, Wada, T, Sakamoto, Y
Publicado em 1994

Expression of major histocompatibility complex class I antigens as a strategy for the potentiation of immune recognition of tumor cells.

Por Tanaka, K, Hayashi, H, Hamada, C, Khoury, G, Jay, G
Publicado em 1986

Statistical analysis of data in mutagenicity assays: rodent micronucleus assay.

Por Hayashi, M, Hashimoto, S, Sakamoto, Y, Hamada, C, Sofuni, T, Yoshimura, I
Publicado em 1994

An individual patient data meta-analysis of adjuvant therapy with uracil–tegafur (UFT) in patients with curatively resected rectal cancer

Por Sakamoto, J, Hamada, C, Yoshida, S, Kodaira, S, Yasutomi, M, Kato, T, Oba, K, Nakazato, H, Saji, S, Ohashi, Y
Publicado em 2007

Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of...

Por Sadahiro, S., Tsuchiya, T., Sasaki, K., Kondo, K., Katsumata, K., Nishimura, G., Kakeji, Y., Baba, H., Sato, S., Koda, K., Yamaguchi, Y., Morita, T., Matsuoka, J., Usuki, H., Hamada, C., Kodaira, S.
Publicado no Ann Oncol (2015)

PD-014 Final survival results and onset of neutropenia as an indicator of therapeutic effect in phase 2 of TAS-102 vs placebo with metastatic colorectal cancer (J003-10040030)

Por Yoshino, T., Shinozaki, E., Yamazaki, K., Nishina, T., Komatsu, Y., Baba, H., Tsuji, A., Yamaguchi, K., Muro, K., Sugimoto, N., Tsuji, Y., Moriwaki, T., Esaki, T., Hamada, C., Tanase, T., Ohtsu, A.
Publicado no Ann Oncol (2016)

A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC)

Por Oki, E., Murata, A., Yoshida, K., Maeda, K., Ikejiri, K., Munemoto, Y., Sasaki, K., Matsuda, C., Kotake, M., Suenaga, T., Matsuda, H., Emi, Y., Kakeji, Y., Baba, H., Hamada, C., Saji, S., Maehara, Y.
Publicado no Ann Oncol (2016)

Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer

Por Ioka, T, Komatsu, Y, Mizuno, N, Tsuji, A, Ohkawa, S, Tanaka, M, Iguchi, H, Ishiguro, A, Kitano, M, Satoh, T, Yamaguchi, T, Takeda, K, Kida, M, Eguchi, K, Ito, T, Munakata, M, Itoi, T, Furuse, J, Hamada, C, Sakata, Y
Publicado no Br J Cancer (2017)

Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer

Por Ohkawa, S, Okusaka, T, Isayama, H, Fukutomi, A, Yamaguchi, K, Ikeda, M, Funakoshi, A, Nagase, M, Hamamoto, Y, Nakamori, S, Tsuchiya, Y, Baba, H, Ishii, H, Omuro, Y, Sho, M, Matsumoto, S, Yamada, N, Yanagimoto, H, Unno, M, Ichikawa, Y, Takahashi, S, Watanabe, G, Wakabayashi, G, Egawa, N, Tsuda, M, Hosotani, R, Hamada, C, Hyodo, I
Publicado no Br J Cancer (2015)